Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and ...

It has been about a month since the last earnings report for Tandem Diabetes Care, Inc. (TNDM). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

Citigroup cut Tandem Diabetes Care from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $35.00 to $24.00 in a research note on Tuesday, March 4th.

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

– Additional data presented at the 18th International Conference on Advanced Technologies & Treatments for Diabetes – Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and ...

CMO Jordan Pinsker said Tandem hopes to expand Medicare coverage of its automated insulin delivery systems using new data shared at ATTD.

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...